Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study

Pauline MJ Steylen1 Vincent van Gogh Institute for Psychiatry, Center of Excellence for Neuropsychiatry, Venray, the NetherlandsCorrespondence[email protected] [email protected]

Frank MMA van der Heijden1 Vincent van Gogh Institute for Psychiatry, Center of Excellence for Neuropsychiatry, Venray, the Netherlands

Witte JG Hoogendijk2 Erasmus University Medical Center, Department of Psychiatry, Rotterdam, the Netherlands

Willem MA Verhoeven1 Vincent van Gogh Institute for Psychiatry, Center of Excellence for Neuropsychiatry, Venray, the Netherlands;2 Erasmus University Medical Center, Department of Psychiatry, Rotterdam, the Netherlands

Pages 57-63 | Published online: 23 Jan 2015

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

AlmdalTScharlingHJensenJSVestergaardHThe independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-upArch Intern Med2004164131422 142615249351
PubMedGoogle Scholar
The Emerging Risk Factors CollaborationDiabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesLancet201037597332215 222220609967
PubMed Web of Science ®Google Scholar
The International Expert CommitteeInternational Expert Committee report on the role of the A1c assay in the diagnosis of diabetesDiabetes Care20093271 8
Web of Science ®Google Scholar
American Diabetes AssociationStandard of medical care in diabetes-2011Diabetes Care201134Suppl 1S11 S6121193625
PubMed Web of Science ®Google Scholar
GrundySMPre-diabetes, metabolic syndrome, and cardiovascular riskJ Am Coll Cardiol2012597635 64322322078
PubMed Web of Science ®Google Scholar
MariniMASuccurroECastaldoECardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and haemoglobin A1c criteriaDiabetes Care20123551144 114922399698
PubMed Web of Science ®Google Scholar
PetersenJLMcGuireDKImpaired glucose tolerance and impaired fasting glucose – a review of diagnosis, clinical implications and managementDiab Vasc Dis Res2005219 1516305067
PubMedGoogle Scholar
RheeSYWooJTThe prediabetic period: a review of clinical aspectsDiabetes Metab J201135107 11621738892
PubMedGoogle Scholar
UnwinNShawJZimmetPAlbertiKGImpaired glucose tolerance and impaired fasting glycemia: the current status on definition and interventionDiabet Med200219708 72312207806
PubMed Web of Science ®Google Scholar
FonsecaVAIdentification and treatment of prediabetes to prevent progression to type 2 diabetesClin Cornerstone20078210 1818357952
PubMedGoogle Scholar
RyanMCMCollinsPThakoreJHImpaired fasting glucose tolerance in first-episode, drug naïve patients with schizophreniaAm J Psychiatry20031602284 28912562574
PubMed Web of Science ®Google Scholar
SaddichhaSAmeenSAkhtarSIncidence of new onset metabolic syndrome with atypical antipsychotics in first episode schizophrenia: a six-week prospective study in Indian female patientsSchizophr Res2007951–324717644311
PubMed Web of Science ®Google Scholar
GladigauELFazioTNHannamJPDawsonLMJonesSGIncreased cardiovascular risk in patients with severe mental illnessIntern Med J201444165 6924383746
PubMed Web of Science ®Google Scholar
CitromeLLHoltRIZachryWMRisk of treatment-emergent diabetes mellitus in patients receiving antipsychoticsAnn Pharmacother200741101593 160317785613
PubMed Web of Science ®Google Scholar
van WinkelRDe HertMWampersMMajor changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disordersJ Clin Psychiatry2008693472 47918348593
PubMed Web of Science ®Google Scholar
VancampfortDWampersMMitchellAJA meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controlsWorld Psychiatry2013123240 25024096790
PubMed Web of Science ®Google Scholar
MitchellAJHardySAScreening for metabolic risk among patients with severe mental illness and diabetes: a national comparisonPsychiatr Serv201364101060 106324081407
PubMed Web of Science ®Google Scholar
De HertMvan WinkelRSilicAVan EyckDPeuskensJPhysical health management in psychiatric settingsEur Psychiatry201025Suppl 2S22 S2820620882
PubMed Web of Science ®Google Scholar
ManuPCorrellCUvan WinkelRWampersMDe HertMPrediabetes in patients treated with antipsychotic drugsJ Clin Psychiatry2012734460 46622225552
PubMed Web of Science ®Google Scholar
GrahamIAtarDBorch-JohnsenKEuropean guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)Eur Heart J200728192375 241417726041
PubMed Web of Science ®Google Scholar
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in AdultsExecutive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA2001285192486 249711368702
PubMed Web of Science ®Google Scholar
Nationaal Kompas Volksgezondheid (homepage on the Internet)Rijksinstituut voor Volksgezondheid en Milieu (RIVM) [updated June 5, 2014]. Available from: http://www.nationaalkompas.nl/gezondheid-en-ziekte/ziekten-en-aandoeningen/endocriene-voedings-en-stofwisselingsziekten-en-immuniteitsstoornissen/diabetes-mellitus/omvang/Accessed June 22, 2014
Google Scholar
ScheenAJDe HertMAAbnormal glucose metabolism in patients treated with antipsychoticsDiabetes Metab2007333169 17517412628
PubMed Web of Science ®Google Scholar
World Health OrganizationUse of Glycated Haemoglobin (HbA_1c) in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO ConsultationGenevaWorld Health Organization2011 Available from: http://www.who.int/diabetes/publications/report-hba1c_2011.pdfAccessed June 22, 2014
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Glycosylated hemoglobin as a screening test for hyperglycemia in antipsychotic-treated patients: a follow-up study

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date